<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Radiation-induced peripheral malignant nerve sheath tumor arising from vestibular schwannoma after linac-based stereotactic radiation therapy: a case report and review of literatures.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Radiation-induced peripheral malignant nerve sheath tumor arising from vestibular schwannoma after linac-based stereotactic radiation therapy: a case report and review of literatures." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399549/bin/CRIM2012-648191.003.jpg"/> </div> <div class="text-side"> <h1>Radiation-induced peripheral malignant nerve sheath tumor arising from vestibular schwannoma after linac-based stereotactic radiation therapy: a case report and review of literatures.</h1> <p>Histopathology of the first diagnosis of schwannoma (1(a), ×40), histopathology of the following specimen showing malignant peripheral nerve sheath tumor (MPNST) arising in schwannoma (1(b), ×40), MPNST with chondrosarcomatous component (1(c), ×40), MPNST with area composed of round cell tumor and brisk mitotic activity (1(d), ×100), MPNST with pleomorphic nuclei (1(e), ×400), MPNST with rhabdomyoblastic differentiation (1(f), ×400), MPNST showing immunonegativity for S-100 (1(g), X400), MPNST showing sarcomeric actin immunoreactivity (1(h), ×400), and MPNST with high Ki-67 immunohistochemistry (1(i), ×400).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/22829840/" target="_blank">22829840</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>